Nano-modified viruses prime the tumor microenvironment and promote the photodynamic virotherapy in liver cancer
Abstract Background As of 2020, hepatocellular carcinoma (HCC), a form of liver cancer, stood as the third most prominent contributor to global cancer-related mortality. Combining immune checkpoint inhibitors (ICI) with other therapies has shown promising results for treating unresectable HCC, offer...
Main Authors: | Da-Liang Ou, Zi-Xian Liao, Ivan M. Kempson, Lin Li, Pan-Chyr Yang, S.-Ja Tseng |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2024-01-01
|
Series: | Journal of Biomedical Science |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12929-023-00989-1 |
Similar Items
-
Oncolytic Virotherapy and Microenvironment in Multiple Myeloma
by: Valentina Marchica, et al.
Published: (2021-02-01) -
Cross Talk of Macrophages with Tumor Microenvironment Cells and Modulation of Macrophages in Cancer by Virotherapy
by: Sarah Di Somma, et al.
Published: (2021-09-01) -
In Vivo Oncolytic Virotherapy in Murine Models of Hepatocellular Carcinoma: A Systematic Review
by: Muhammad Joan Ailia, et al.
Published: (2022-09-01) -
Oncolytic Virotherapy: A New Paradigm in Cancer Immunotherapy
by: Simona Ruxandra Volovat, et al.
Published: (2024-01-01) -
Oncolytic Virotherapy in Glioma Tumors
by: Sergio Rius-Rocabert, et al.
Published: (2020-10-01)